142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

305588
Variation in preventive medication for acute myocardial infarction in Taiwan: Evidence showing that universal coverage cannot provide equal access to optimal care

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Raymond Kuo, PhD , Institute of Health Policy and Management, National Taiwan University, Taipei City, Taiwan
Chao-lun Lai, MD, PhD , Division of Cardiology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan
Yi-Chun Yeh, MS , Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, Taiwan
Yen-Yun Yang, MS , Center of Comparative Effectiveness Research, National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei City, Taiwan
Ho-Min Chen, MS , Center for Comparative Effectiveness Research, National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan, Taipei, Taiwan
Mei-Shu Lai, MD, PhD , Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei City, Taiwan
Raymond Kuo, PhD , Institute of Health Policy and Management, National Taiwan University, Taipei City, Taiwan
Introduction/Objective

Preventive medication prescribed at discharge for acute myocardial infarction (AMI) is recommended by clinical practice guidelines. The prescribing rates of preventive medication have been widely used as quality indicators for the process of care at the provider-level. It remains unknown whether disparities in receiving preventive medication remain exist between socioeconomic classes and types of providers within a universal healthcare system in which drug costs are covered.

Methods

This study employed population-based claims data from the National Health Insurance database for the period 2008-2010. Patients who were admitted to hospital with AMI as their primary diagnosis were included in the study. The adherence rates of five types of drugs prescribed at discharge, including beta blockers, statins, ACEI/ ARB, aspirin and clopidogrel, were calculated for each hospital in each year. Hierarchical generalized linear modeling was used to assess the influence of types of hospital as well as the patient's socioeconomic status on the administration of preventive medication.

Results

A total of 41,237 AMI patients discharged from 258 hospitals (19 medical centers, 74 regional hospitals, 165 district, small hospitals) were included in this study. The mean adherence rates among medical centers, regional hospitals, and small hospitals in prescribing beta blockers (64.6%, 50.5%, 28.6%, respectively), statins (61.7%, 39.3%, 13.8%, respectively), ACEI/ ARB (75.5%, 60.3%, 38.3%, respectively), aspirin (90.6%, 82.3%, 53.9%, respectively) and clopidogrel (91.1%, 75.9%, 28.6%, respectively) varied greatly. The results of hierarchical generalized linear models show that after controlling for patient's age, gender, and year of index hospitalization, patients admitted to medical centers and regional hospitals were associated with high rates of administration of preventive medications (OR: 1.71-47.77,p<.001). In hospitals located in areas with lower educational levels, patients were less likely to receive statins and aspirin (OR: 0.06 and 0.22, p<.001). Patients with lower income levels were less likely to receive any of the other preventive medications (OR: 0.84-0.92,p<.001), with the exception of aspirin.

Conclusion

Our results illustrate the extreme variance in adherence to preventive medication for post-discharge AMI patients that remains under Taiwan's National Health Insurance. This study provides evidence that the expansion of coverage does not necessarily reduce all disparities. Actions to monitor and improve quality of care remain important, even in cases where health care costs are covered.

Learning Areas:

Administration, management, leadership
Chronic disease management and prevention
Provision of health care to the public
Public health or related research

Learning Objectives:
Evaluate if disparities in receiving preventive medication remain exist within a universal healthcare system in which drug costs are covered; Assess the influence of patient's socioeconomic status on the administration of preventive medication; Compare the prescribing rates of preventive medication between different types of hospitals.

Keyword(s): Health Disparities/Inequities, Quality of Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: The study is designed by me and completed by all the co-authors listed on the abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.